PERSPECTA

News from every angle

Back to headlines

Moderna Exceeds Revenue Estimates on Strong Vaccine Sales

Moderna has surpassed its revenue estimates, driven by robust international sales of its COVID-19 vaccine. This performance indicates continued demand for its pharmaceutical products globally.

PostShare

Sources

Showing 0 of 2 sources

No articles available in your preferred languages.

2 articles available in other languages below.